US FDA tightens regulations for use of erythopoiesis-stimulating agents

被引：0
作者：
不详
机构：
来源：
EXPERT REVIEW OF ANTICANCER THERAPY | 2010年 / 10卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：483 / 483
页数：1
相关论文
共 50 条
[21]   Use of agents stimulating erythropoiesis in digestive diseases [J].
Moreno Lopez, Rosario ;
Sicilia Aladren, Beatriz ;
Gomollon Garcia, Fernando .
WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (37) :4675-4685
[22]   Developments in the therapeutic use of erythropoiesis stimulating agents [J].
Jelkmann, Wolfgang .
BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 (03) :287-297
[23]   Preclinical studies conducted on nanozyme antioxidants: shortcomings and challenges based on US FDA regulations [J].
Ghorbani, Milad ;
Izadi, Zhila ;
Jafari, Samira ;
Casals, Eudald ;
Rezaei, Foroogh ;
Aliabadi, Alireza ;
Moore, Alycia ;
Ansari, Ali ;
Puntes, Victor ;
Jaymand, Mehdi ;
Derakhshankhah, Hossein .
NANOMEDICINE, 2021, 16 (13) :1133-1151
[24]   US FDA panel backs wider use of rosuvastatin [J].
不详 .
EJHP PRACTICE, 2010, 16 (02) :14-14
[25]   US FDA panel backs wider use of rosuvastatin [J].
不详 .
EJHP PRACTICE, 2010, 16 (01) :14-14
[26]   US FDA restricts codeine and tramadol use in children [J].
Reactions Weekly, 2017, 1649 (1) :6-6
[27]   US FDA announces launch of Safe Use Initiative [J].
Reactions Weekly, 2009, 1278 (1) :1-1
[28]   US FDA requests warnings for micro-bubble contrast agents [J].
Reactions Weekly, 2007, 1174 (1) :3-3
[29]   Evaluation of the Use of Inpatient Erythropoiesis-Stimulating Agents [J].
Hughes, Sarah ;
Smoak, Julia ;
Kelly, Gaffney .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2025, 82 :S958-S958
[30]   Clinical use of the erythropoietin stimulating agents: defining the risks [J].
Kosmidis, Paris A. .
JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) :S155-S156
12345